Minerva Neurosciences Inc (NASDAQ:NERV)
| 9.79 BATS BZX Real-Time Price As of 3:09pm ET |  +0.24 / +2.51%Today’s Change | 2.51 Today|||52-Week Range 15.27 | +52.78% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 14.4M | 83.1M | 26.1M | 50.3M | |
| Short Term Investment Cash | -4.2M | 68.7M | -56.9M | 24.2M | ||
| Cash & Short Term Investments | 32.3M | 83.1M | 128.2M | 88.1M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 1.2M | 803.2K | 1.3M | 1.9M | |
| Current Assets | 33.5M | 83.9M | 129.5M | 90.0M | ||
| Total Assets | Intangible Assets | 49.1M | 49.1M | 49.1M | 49.1M | |
| Other Assets | 49.1M | 49.1M | 49.1M | 49.1M | ||
| Total Assets | 82.6M | 132.9M | 189.0M | 144.4M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 1.4M | 1.8M | |
| Short Term Debt | 1.4M | 4.9M | 4.0M | 0.00 | ||
| Accrued Expenses | 1.7M | 3.3M | 1.4M | 1.8M | ||
| Other Current Liabilities | 3.2M | 4.8M | 1.4M | 1.8M | ||
| Other Liabilities | 5.3M | 9.7M | 6.8M | 3.6M | ||
| Total Liabilities | Long Term Debt | 8.5M | 3.8M | 0.00 | 0.00 | |
| Deferred Taxes | -13.4M | -13.4M | -4.1M | -4.1M | ||
| Other Liabilities | 0.00 | 0.00 | 29.9K | 29.0K | ||
| Total Liabilities | 27.3M | 27.0M | 57.4M | 54.2M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 55.3M | 106.0M | 131.6M | 90.3M | ||
| Total Shareholder Equity | 55.3M | 106.0M | 131.6M | 90.3M | ||
| Share Information | Common Shares Outstanding | 24.7M | 35.0M | 38.7M | 38.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
